Table 3– Outcome during 3 months following pulmonary embolism
First author [Ref.]Patients nRecurrent VTE95% CIMortality95% CIMajor bleeding95% CI
Outpatients
 Agterof [4]15200.0–2.400.0–2.400.0–2.4
  Aujesky [5]1711 (0.6)0.01–3.21 (0.6)0.01–3.23 (1.8)0.4–4.7
 Beer [20]431 (2.3)0.06–12.300.0–6.700.0–6.7
 Erkens [6]26010 (3.8)1.9–7.013 (5)2.7–8.44 (1.5)0.4–3.9
 Kovacs [22]815 (6.2)2.0–13.84 (4.9)1.4–12.21 (1.2)0.03–6.7
 Kovacs [7]3143 (0.95)0.2–2.89 (2.9)1.3–5.43 (0.95)0.2–2.8
 Lui [23]#2100.0–16.100.0–16.100.0–16.1
 Olsson [24]10200.0–3.64 (3.9)1.1–9.7
 Ong [25]603 (5.0)1.0–13.91 (1.7)0.04–8.91 (1.7)0.04–8.9
 Rodriguez-Cerrillo [27]3000.0–11.600.0–11.600.0–11.6
 Siragusa [28]362 (5.5)0.7–18.711 (30.5)16.4–48.11 (2.7)0.07–14.5
 Wells [29]902 (2.2)0.3–7.83 (3.3)0.7–9.400.0–4.0
 Zondag [8]2976 (2.0)0.8–4.33 (1.0)0.2–2.92 (0.67)0.008–1.9
Early discharge
 Davies [21]15700.0–2.33 (1.9)0.4–5.500.0–2.3
 Kovacs [22]271 (3.7)0.09–19.000.0–12.81 (3.7)0.09–19.0
 Otero [26]722 (2.8)0.33–9.73 (4.2)0.87–11.71 (1.4)0.03–7.5
Inpatients
 Aujesky [5]16800.0–1.800.0–1.81 (0.6)0.01–3.3
 Beer [20]542/65 (3.1)+0.4–10.700–5.500–5.5
 Ong [25]704 (5.7)1.6–14.03 (4.3)0.9–12.02 (2.9)0.3–9.9
 Otero [26]602 (3.3)0.41–11.55 (8.3)2.8–18.41 (1.6)0.04–8.9
 Rodriguez-Cerrillo [27]3100.0–11.200.0–11.200.0–11.2
  • Data are presented as n (%) or mean±sd, unless otherwise stated. VTE: venous thromboembolism. #: mean duration of follow-up 6 days (range 3–11), no long-term outcome available; : outcome measured at 6 months after diagnosis of pulmonary embolism (PE); +: two recurrent PEs in total inpatient group (n=65), but not specified for high- (n=11) or low-risk (n=54) group.